ESR1 and neoplasm: This could be due to the reduced ability of ERα knockdown PacMetUT1 to invade and migrate into the bone marrow as our in vitro studies suggested that the blockade of ERα signaling inhibited EMT, which is known to promote tumor cell migration and invasion.